TransMedics (TMDX) Operating Margin (2018 - 2026)

TransMedics has reported Operating Margin for 9 years, with the latest figure at 12.5% in Q2 2026.

• On a quarterly basis, Operating Margin fell 1074.0% year-over-year to 12.5% in Q2 2026; TTM through Jun 2026 was 12.21%, a 221.0% decrease from a year earlier, with the FY2025 full-year figure at 17.93%, up 944.0% from the prior year.
• Operating Margin was 12.5% for Q2 2026 at TransMedics, up from 7.64% in the prior quarter.
• The five-year high for Operating Margin was 23.24% in Q2 2025, with the low at 59.0% in Q1 2022.
• Average Operating Margin over 5 years is 3.86%, with a median of 5.36% recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Operating Margin jumped 19502 bps in 2022, then tumbled 2107 bps in 2023.
• Over 5 years, Operating Margin stood at 21.61% in 2022, then surged by 115 bps to 3.21% in 2023, then jumped by 122 bps to 7.11% in 2024, then jumped by 86 bps to 13.23% in 2025, then retreated by 6 bps to 12.5% in 2026.
• The last three Operating Margin figures came in at 12.5% (Q2 2026), 7.64% (Q1 2026), and 13.23% (Q4 2025), per Business Quant data.